List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1500 studies with search of: "Insulin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: insulin aspart and detemir (NovoRapid, Levemir);   Drug: human regular insulin and NPH insulin (Actrapid, Protaphne)
2 Completed Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Regular insulin (Humulin);   Drug: Insulin lispro (Humalog)
3 Recruiting Insulin Therapy in the Hospital Comparing Two Protocols
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine insulin;   Drug: NPH insulin and regular insulin;   Drug: lispro insulin
4 Recruiting Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients
Conditions: Diabetes Type 2;   Weight Gain
Interventions: Drug: Insulin Detemir; Insulin Insulatard;   Drug: Insulin Detemir, Insulin Insulatard
5 Recruiting Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects
Condition: Diabetes
Interventions: Biological: Isophane insulin for inj. (Recomb Human insulin) (Wosulin N);   Biological: Isophane insulin for inj.(Recomb. Human Insulin) (Novolin N)
6 Active, not recruiting Efficacy and Safety of Insulin Detemir Versus NPH Insulin in Pregnant Women With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: insulin detemir;   Drug: insulin NPH;   Drug: insulin aspart
7 Active, not recruiting Tight Glycemic Control With Intensive Insulin Therapy in PICU
Condition: Critical Illness in Infant or Child in ICU
Interventions: Drug: intensive insulin therapy (Actrapid IV to normoglycemia);   Drug: conventional insulin therapy (Actrapid IV only for excessive hyperglycemia)
8 Active, not recruiting SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c
Condition: Diabetes Mellitus, Type 1
Interventions: Device: insulin pump with continuous glucose sensing (Paradigm Real-Time Insulin Pump System);   Device: insulin pump and blinded continuous glucose sensing (Paradigm Real-Time insulin pump)
9 Recruiting Insulin Detemir Action in Cerebro
Condition: Type 1 Diabetes
Interventions: Drug: Insulin detemir;   Drug: Insulin NPH
10 Completed Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: insulin detemir;   Drug: insulin NPH;   Drug: insulin aspart
11 Recruiting Preservation of Pancreatic Beta Cell Function Through Insulin Pump Therapy
Condition: Diabetes Mellitus
Interventions: Drug: MDI (split-mix NPH insulin + regular insulin or Lantus + Novolog® [or Humalog®]);   Device: CSII (Animas Corporation insulin pump, model IR 1200)
12 Active, not recruiting Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-Diabetic Agents
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: soluble human insulin;   Drug: biphasic human insulin;   Drug: insulin NPH;   Drug: insulin aspart;   Drug: biphasic insulin aspart;   Drug: insulin detemir
13 Recruiting Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics
Condition: Diabetes
Interventions: Biological: Regular insulin for inj. (Recomb.Humain Insulin) (Wosulin R);   Biological: Regular insulin for inj.(Recomb.Human Insulin)(Actrapid)
14 Terminated Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: insulin detemir;   Drug: insulin NPH;   Drug: insulin aspart
15 Completed Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Detemir + aspart insulin before meals;   Drug: NPH insulin + regular insulin
16 Completed A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: pramlintide acetate;   Drug: rapid acting insulin (Humalog® [insulin lispro], Novolog® [insulin aspart], or Apidra® [insulin glulisine]);   Drug: basal insulin (Lantus® [insulin glargine], or Levemir® [insulin detemir])
17 Completed A Study to Evaluate the Effect of Nasal Insulin on Postprandial Glycemic Control in Type 2 Diabetic Patients
Condition: Diabetes Mellitus
Interventions: Drug: Insulin (recombinant human insulin);   Drug: NovoLog
18 Active, not recruiting Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Insulin glulisine;   Drug: Insulin lispro;   Drug: Insulin aspart
19 Completed Basal Insulins - Pharmacodynamics
Condition: Diabetes
Interventions: Drug: Insulin detemir;   Drug: Insulin glargine;   Drug: Insulatard
20 Completed
Has Results 		Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin
Conditions: Hyperglycemia;   Diabetes
Interventions: Drug: insulin glargine;   Drug: insulin glargine;   Drug: insulin glargine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services